Studies related to Neuropathic Pain (In general) and Cannabis

Meta-analysis Of Cannabis Based Treatments For Neuropathic And Multiple Sclerosis-related Pain

Effect Decrease
Values 0-10 point scale. Mean difference from baseline and SE. 1.7 (0.7). Placebo: 0.8 (0.4)
Trial Design Meta analysis
Trial Length n/a
Number of Subjects 0
Sex Both Genders
Notes for this study:
This was a meta-analysis of randomized, double-blind, placebo-controlled trials that used cannabis-based drugs to treat multiple sclerosis or comparable neuropathic pain in adults. Six trials involved CBD with THC, five involved cannabidiol, and three involved dronabinol (only the combination counts for this page).

There was a moderate, statistically significant improvement in pain from THC + CBD buccal spray compared with baseline in the six trials. The difference was greater than placebo, though placebo was based on a larger number of studies and the two weren't compared statistically.
Funding issues for this study:
"This study was funded by Bayer Inc., Toronto,
Canada."

Full details on all 18 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.